BCL2 expression is one of the most influential alterations in DLBCL and is already prognostically significant, as DLBCL with MYC and BCL2/BCL6 mutations are termed double hit or triple hit lymphomas and are associated with a worse prognosis (Xu et al., 2013). The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.